Entactogen: Difference between revisions

Line 1:

The terms '''entactogen''' and '''empathogen''' are used to describe a class of psychoactive drugs that produce distinctive emotional and social effects similar to those of [[MDMA]]. The term "'''empathogen'''" was coined in 1983 by Ralph Metzner to denote chemical agents inducing feelings of empathy. "'''Entactogen'''" was coined by [[David E. Nichols]] as an alternative to "empathogen", attempting to avoid the potential for improper association of the latter with negative connotations related to the Greek root "pathos" (''suffering''); Nichols also thought the word was limiting, and did not cover other therapeutic uses for the drugs that go beyond instilling feelings of empathy. The word "entactogen" is derived from the roots "en" (within), "tactus" (touch) and "gen" (Greek: ''produce''). Neither term is dominant in usage, and, despite their difference in connotation, they are essentially interchangeable, as they refer to precisely the same chemicals.

==History==

{{quote|text=The word "entactogen" refers to compounds that "produce a touching within," and is derived from the roots en (Greek: within), tact's (Latin: touch), and gen (Greek: produce. Entactogen is used to describe a class of psychoactive substances that decrease anxiety; increase trust, self-acceptance, and openness; and allow easier access to memories, providing fertile ground for transformative healing.

Therapists used entactogens such as MDMA in their practice before it was criminalized in 1985. Since that time, much effort has taken place to conduct government-approved scientific research into MDMA's therapeutic potential, which has recently been demonstrated in placebo-controlled studies of MDMA-assisted psychotherapy for subjects with chronic, treatment-resistant posttraumatic stress disorder.|sign=Ralph Metzner, Ph.D.|source=[https://store.maps.org/np/clients/maps/product.jsp?product=801 MAPS]}}

==Subjective effects==

@@ Line 1: / Line 1: @@
 The terms '''entactogen''' and '''empathogen''' are used to describe a class of psychoactive drugs that produce distinctive emotional and social effects similar to those of [[MDMA]]. The term "'''empathogen'''" was coined in 1983 by Ralph Metzner to denote chemical agents inducing feelings of empathy. "'''Entactogen'''" was coined by [[David E. Nichols]] as an alternative to "empathogen", attempting to avoid the potential for improper association of the latter with negative connotations related to the Greek root "pathos" (''suffering''); Nichols also thought the word was limiting, and did not cover other therapeutic uses for the drugs that go beyond instilling feelings of empathy.  The word "entactogen" is derived from the roots "en" (within), "tactus" (touch) and "gen" (Greek: ''produce''). Neither term is dominant in usage, and, despite their difference in connotation, they are essentially interchangeable, as they refer to precisely the same chemicals.
+==History==
+{{quote|text=The word "entactogen" refers to compounds that "produce a touching within," and is derived from the roots en (Greek: within), tact's (Latin: touch), and gen (Greek: produce. Entactogen is used to describe a class of psychoactive substances that decrease anxiety; increase trust, self-acceptance, and openness; and allow easier access to memories, providing fertile ground for transformative healing.
+Therapists used entactogens such as MDMA in their practice before it was criminalized in 1985. Since that time, much effort has taken place to conduct government-approved scientific research into MDMA's therapeutic potential, which has recently been demonstrated in placebo-controlled studies of MDMA-assisted psychotherapy for subjects with chronic, treatment-resistant posttraumatic stress disorder.|sign=Ralph Metzner, Ph.D.|source=[https://store.maps.org/np/clients/maps/product.jsp?product=801 MAPS]}}
 ==Subjective effects==